Drug Therapy

Derek P. Chew, MBBS
Department of Cardiovascular Medicine, Cleveland Clinic

David J. Moliterno, MD
Department of Cardiovascular Medicine, Cleveland Clinic

Address: David J. Moliterno, MD, Department of Cardiovascular Medicine, F25, Cleveland Clinic, 9500 Euclid Avenue, Cleveland, OH 44195; molited@ccf.org

Dr. Moliterno has indicated that he has received grant or research support from the Centocor, Eli Lilly, and Merck corporations.

Derek P. Chew, MBBS
Department of Cardiovascular Medicine, Cleveland Clinic

David J. Moliterno, MD
Department of Cardiovascular Medicine, Cleveland Clinic

Address: David J. Moliterno, MD, Department of Cardiovascular Medicine, F25, Cleveland Clinic, 9500 Euclid Avenue, Cleveland, OH 44195; molited@ccf.org

Dr. Moliterno has indicated that he has received grant or research support from the Centocor, Eli Lilly, and Merck corporations.

Derek P. Chew, MBBS
Department of Cardiovascular Medicine, Cleveland Clinic

David J. Moliterno, MD
Department of Cardiovascular Medicine, Cleveland Clinic

Address: David J. Moliterno, MD, Department of Cardiovascular Medicine, F25, Cleveland Clinic, 9500 Euclid Avenue, Cleveland, OH 44195; molited@ccf.org

Dr. Moliterno has indicated that he has received grant or research support from the Centocor, Eli Lilly, and Merck corporations.

Aaron I. Vinik, MD, PhD
The Strelitz Diabetes Research Institutes, Department of Internal Medicine and Anatomy/Neurobiology, Eastern Virginia Medical School, Norfolk, Virginia

Tomris Erbas, MD
The Strelitz Diabetes Research Institutes, Department of Internal Medicine and Anatomy/Neurobiology, Eastern Virginia Medical School, Norfolk, Virginia

Address: Aaron I. Vinik MD, PhD, The Strelitz Diabetes Research Institutes, 855 West Brambleton Avenue, Norfolk, VA 23510

Dr. Vinik has indicated that he has received grant or research support from multiple pharmaceutical corporations and serves as a consultant on the speakers bureaus of multiple pharmaceutical corporations.

Aaron I. Vinik, MD, PhD
The Strelitz Diabetes Research Institutes, Department of Internal Medicine and Anatomy/Neurobiology, Eastern Virginia Medical School, Norfolk, Virginia

Tomris Erbas, MD
The Strelitz Diabetes Research Institutes, Department of Internal Medicine and Anatomy/Neurobiology, Eastern Virginia Medical School, Norfolk, Virginia

Address: Aaron I. Vinik MD, PhD, The Strelitz Diabetes Research Institutes, 855 West Brambleton Avenue, Norfolk, VA 23510

Dr. Vinik has indicated that he has received grant or research support from multiple pharmaceutical corporations and serves as a consultant on the speakers bureaus of multiple pharmaceutical corporations.

Aaron I. Vinik, MD, PhD
The Strelitz Diabetes Research Institutes, Department of Internal Medicine and Anatomy/Neurobiology, Eastern Virginia Medical School, Norfolk, Virginia

Tomris Erbas, MD
The Strelitz Diabetes Research Institutes, Department of Internal Medicine and Anatomy/Neurobiology, Eastern Virginia Medical School, Norfolk, Virginia

Address: Aaron I. Vinik MD, PhD, The Strelitz Diabetes Research Institutes, 855 West Brambleton Avenue, Norfolk, VA 23510

Dr. Vinik has indicated that he has received grant or research support from multiple pharmaceutical corporations and serves as a consultant on the speakers bureaus of multiple pharmaceutical corporations.

Matt E. Kalaycio, MD
Director, Leukemia Program, Department of Hematology and Medical Oncology, The Cleveland Clinic

Address: Matt E. Kalaycio, MD, Department of Hematology and Medical Oncology, R35,  Cleveland Clinic, 9500 Euclid Avenue, Cleveland, OH 44195; kalaycm@ccf.org

Dr. Kalaycio has indicated that he has received grant research support from Sangstat, Novartis, Genta, and Protein Design Labs, and that he is on the speakers bureau of Cell Therapeutics.

This article disscusses therapies that are not yet FDA-approved for the use under discussion and are investigational.

Matt E. Kalaycio, MD
Director, Leukemia Program, Department of Hematology and Medical Oncology, The Cleveland Clinic

Address: Matt E. Kalaycio, MD, Department of Hematology and Medical Oncology, R35,  Cleveland Clinic, 9500 Euclid Avenue, Cleveland, OH 44195; kalaycm@ccf.org

Dr. Kalaycio has indicated that he has received grant research support from Sangstat, Novartis, Genta, and Protein Design Labs, and that he is on the speakers bureau of Cell Therapeutics.

This article disscusses therapies that are not yet FDA-approved for the use under discussion and are investigational.

Matt E. Kalaycio, MD
Director, Leukemia Program, Department of Hematology and Medical Oncology, The Cleveland Clinic

Address: Matt E. Kalaycio, MD, Department of Hematology and Medical Oncology, R35,  Cleveland Clinic, 9500 Euclid Avenue, Cleveland, OH 44195; kalaycm@ccf.org

Dr. Kalaycio has indicated that he has received grant research support from Sangstat, Novartis, Genta, and Protein Design Labs, and that he is on the speakers bureau of Cell Therapeutics.

This article disscusses therapies that are not yet FDA-approved for the use under discussion and are investigational.

Glen D. Solomon, MD
Senior Medical Director, Department of Medical and Scientific Affairs, US Human Health, Merck and Company, Inc; consultant, Departments of Neurology and General Internal Medicine, The Cleveland Clinic

Address: Glen D. Solomon, MD, 42 Bradford Lane, Oak Brook, IL 60523

Dr. Solomon discusses therapies that are either investigative or not yet labeled for the use under discussion.

Glen D. Solomon, MD
Senior Medical Director, Department of Medical and Scientific Affairs, US Human Health, Merck and Company, Inc; consultant, Departments of Neurology and General Internal Medicine, The Cleveland Clinic

Address: Glen D. Solomon, MD, 42 Bradford Lane, Oak Brook, IL 60523

Dr. Solomon discusses therapies that are either investigative or not yet labeled for the use under discussion.

Glen D. Solomon, MD
Senior Medical Director, Department of Medical and Scientific Affairs, US Human Health, Merck and Company, Inc; consultant, Departments of Neurology and General Internal Medicine, The Cleveland Clinic

Address: Glen D. Solomon, MD, 42 Bradford Lane, Oak Brook, IL 60523

Dr. Solomon discusses therapies that are either investigative or not yet labeled for the use under discussion.